GI Division Director Justice Returns To Oncology Review Management
Former Gastrointestinal-& Coagulation Drug Products Division Director Robert Justice, MD, is returning to FDA's oncology product review team as deputy director of the Division of Therapeutic Biological Oncology Products
You may also be interested in...
Genentech Senior Clinical Scientist Robert Justice, MD, is returning to FDA as director of the Division of Gastrointestinal & Coagulation Drug Products in September
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials